This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Clinical Genomics Pty. Ltd.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Susan O'Connor: Innovator in Nucleic Acid Markers
Introduction
Susan O'Connor is a prominent inventor based in Prospect, Australia. She has made significant contributions to the field of molecular biology, particularly in the development of nucleic acid markers that aid in the diagnosis and treatment of neoplasms. Her innovative work has the potential to impact the medical community significantly.
Latest Patents
Susan O'Connor holds a patent for "Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma." This invention relates to novel nucleic acid molecules whose expression levels are indicative of the onset and progression of gastrointestinal tract neoplasms, such as adenomas. The patent encompasses isolated proteins encoded by these nucleic acid molecules and their derivatives, homologues, and analogues. The applications of this invention are vast, including prophylactic, therapeutic, and diagnostic uses, particularly in diagnosing colorectal neoplasms.
Career Highlights
O'Connor is associated with Clinical Genomics Pty. Ltd., where she continues to advance her research and innovations. Her work has garnered attention for its potential to improve early detection and treatment strategies for colorectal cancer.
Collaborations
Some of her notable coworkers include Robert James and Julianne Henry, who have collaborated with her on various projects within the field.
Conclusion
Susan O'Connor's contributions to the field of molecular biology through her innovative patent on nucleic acid markers highlight her role as a leading inventor. Her work promises to enhance the understanding and treatment of neoplasms, paving the way for advancements in medical diagnostics and therapeutics.